Manchester Cancer Research Centre

mcrcnews.bsky.social

01 October 2026 15:19

New research presented at #ASTRO2026 suggests radio-resistance in muscle-invasive bladder cancer can evolve during treatment. Professor Ananya Choudhury (@achoud72.bsky.social) highlighted potential biomarkers that could support more personalised radiotherapy. www.urotoday.com/conference-h...

The OncoAlert Network 🚨

oncoalert.bsky.social

18 May 2026 13:28

Day TWO of #ESTRO26 Coverage by OncoAlert 🚨 Influence of FLAIR Inclusion on Recurrence Patterns and Outcomes in Glioblastoma: Results from a Prospective Adaptive Radiotherapy Trial (UNITED) Presented by Suman Ghosh 🇨🇦 #RadOnc ☢️ @estroradiotherapy.bsky.social

The OncoAlert Network 🚨

oncoalert.bsky.social

18 May 2026 13:28

Day TWO of #ESTRO26 Coverage by OncoAlert 🚨 De-intensification of postoperative radiotherapy in HNSCC by omitting contralateral elective neck irradiation– long term outcomes of the DIREKHT trial Presented by Charlotte Frei 🇩🇪 #RadOnc ☢️ @estroradiotherapy.bsky.social

The OncoAlert Network 🚨

oncoalert.bsky.social

18 May 2026 13:28

Day TWO of #ESTRO26 Coverage by OncoAlert 🚨 Paradigm shift from bilateral elective nodal irradiation to SPECT/CT-based SNP to guide unilateral irradiation in HNSCC: multicenter prospective study Presented by Abrahim Al-Mamgani🇳🇱

The OncoAlert Network 🚨

oncoalert.bsky.social

18 May 2026 13:28

Day TWO of #ESTRO26 Coverage by OncoAlert 🚨 Final results of a nationwide multicenter randomized trial (GOLD) on hypofractionated chemoradiation for glioblastoma: survival and HRQoL Presented by Anouk de Jong 🇳🇱 #RadOnc ☢️ @estroradiotherapy.bsky.social